Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

[The vocal behavior of telemarketing operators before and after a working day].

Amorim GO, Bommarito S, Kanashiro CA, Chiari BM.

J Soc Bras Fonoaudiol. 2011;23(2):170-6. Portuguese.

PMID:
21829934
2.

Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.

Hohla F, Schally AV, Kanashiro CA, Buchholz S, Baker B, Kannadka C, Moder A, Aigner E, Datz C, Halmos G.

Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18671-6. Epub 2007 Nov 14.

3.

The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.

Stangelberger A, Schally AV, Zarandi M, Heinrich E, Groot K, Havt A, Kanashiro CA, Varga JL, Halmos G.

Prostate. 2007 Sep 1;67(12):1339-53.

PMID:
17624923
4.

alpha- and epsilon-protein kinase C activity during smooth muscle cell apoptosis in response to gamma-radiation.

Claro S, Kanashiro CA, Oshiro ME, Ferreira AT, Khalil RA.

J Pharmacol Exp Ther. 2007 Sep;322(3):964-72. Epub 2007 Jun 28.

PMID:
17600140
5.
6.

Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel.

Hohla F, Schally AV, Szepeshazi K, Varga JL, Buchholz S, Köster F, Heinrich E, Halmos G, Rick FG, Kannadka C, Datz C, Kanashiro CA.

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14513-8. Epub 2006 Sep 18.

7.

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.

Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, Köster F, Kovitz K, Groot K, Zarandi M, Kanashiro CA.

Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17424-9. Epub 2005 Nov 18.

8.

Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.

Stangelberger A, Schally AV, Varga JL, Zarandi M, Cai RZ, Baker B, Hammann BD, Armatis P, Kanashiro CA.

Eur J Cancer. 2005 Nov;41(17):2735-44.

PMID:
16291086
9.

Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.

Stangelberger A, Schally AV, Nagy A, Szepeshazi K, Kanashiro CA, Halmos G.

Prostate. 2006 Feb 1;66(2):200-10.

PMID:
16173040
10.

Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma.

Kanashiro CA, Schally AV, Varga JL, Hammann B, Halmos G, Zarandi M.

Cancer Lett. 2005 Aug 26;226(2):123-31.

PMID:
16039952
11.

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.

Stangelberger A, Schally AV, Letsch M, Szepeshazi K, Nagy A, Halmos G, Kanashiro CA, Corey E, Vessella R.

Int J Cancer. 2006 Jan 1;118(1):222-9.

13.
15.

Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.

Kanashiro CA, Schally AV, Groot K, Armatis P, Bernardino AL, Varga JL.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15836-41. Epub 2003 Dec 5.

16.

Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.

Szereday Z, Schally AV, Varga JL, Kanashiro CA, Hebert F, Armatis P, Groot K, Szepeshazi K, Halmos G, Busto R.

Cancer Res. 2003 Nov 15;63(22):7913-9.

17.

Ligand-induced endocytosis and nuclear localization of angiotensin II receptors expressed in CHO cells.

Merjan AJ, Kanashiro CA, Krieger JE, Han SW, Paiva AC.

Braz J Med Biol Res. 2001 Sep;34(9):1175-83.

18.

Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle.

Kanashiro CA, Khalil RA.

Am J Physiol Cell Physiol. 2001 Jan;280(1):C34-45.

19.
20.

Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis.

Kanashiro CA, Cockrell KL, Alexander BT, Granger JP, Khalil RA.

Am J Physiol Regul Integr Comp Physiol. 2000 Feb;278(2):R295-303.

21.

Ca(2+)-insensitive vascular protein kinase C during pregnancy and NOS inhibition.

Kanashiro CA, Alexander BT, Granger JP, Khalil RA.

Hypertension. 1999 Oct;34(4 Pt 2):924-30.

PMID:
10523386
22.
23.

Signal transduction by protein kinase C in mammalian cells.

Kanashiro CA, Khalil RA.

Clin Exp Pharmacol Physiol. 1998 Dec;25(12):974-85. Review.

PMID:
9887993
24.

Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction.

Han HM, Shimuta SI, Kanashiro CA, Oliveira L, Han SW, Paiva AC.

Mol Endocrinol. 1998 Jun;12(6):810-4.

PMID:
9626656
25.

Angiotensin II tachyphylaxis in the guinea pig ileum and its prevention: a pharmacological and biochemical study.

Kanashiro CA, Paiva TB, Paiva AC, Prioste RN, Aboulafia J, Shimuta SI.

J Pharmacol Exp Ther. 1995 Dec;275(3):1543-50.

PMID:
8531127
26.

Role of Na+ and protein kinase C in angiotensin desensitization and tachyphylaxis in the guinea-pig ileum.

Shimuta SI, Kanashiro CA, Ferreira AT, Oshiro ME, Paiva TB, Paiva AC.

Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):425-31.

PMID:
8510770
27.

Angiotensin II desensitization and Ca++ and Na+ fluxes in cultured intestinal smooth muscle cells.

Shimuta SI, Kanashiro CA, Oshiro ME, Paiva TB, Paiva AC.

J Pharmacol Exp Ther. 1990 Jun;253(3):1215-21.

PMID:
2359022

Supplemental Content

Loading ...
Support Center